Human Milk for Premature Infants
(MAGIC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how varying amounts of human milk affect the body composition of moderately preterm infants, specifically those born between 27 and 31 weeks of gestation. The study compares two groups: one receiving 180-200 mL/kg/day of human milk and another receiving 140-160 mL/kg/day. Ideal participants are preterm infants who have been fed human milk and reached full feeding levels within the first 14 days after birth. As an unphased trial, this study provides a unique opportunity to enhance understanding of optimal nutrition for preterm infants.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What prior data suggests that this human milk diet is safe for premature infants?
Research has shown that using human milk for premature babies is safe and beneficial. Studies have found that feeding these babies with human milk can lower the risk of necrotizing enterocolitis (NEC), particularly in very small infants weighing less than 1250 grams. One study found that using fresh human milk for preterm babies is practical and safe, potentially improving their overall health.
These findings suggest that premature infants tolerate human milk well and can gain important health benefits, making it a safe choice for their nutrition.12345Why are researchers excited about this trial?
Researchers are excited about using human milk for premature infants because it taps into the natural benefits of breast milk, which is uniquely suited to meet the nutritional needs of newborns. Unlike formula, which is a common standard of care, human milk contains antibodies and growth factors that can help strengthen the immune system and support development. The study is exploring different volumes of human milk to see if higher amounts can lead to even better health outcomes for premature infants, potentially reducing complications and improving growth rates. This approach could offer a more natural and potentially more effective option for supporting the health of these vulnerable babies.
What evidence suggests that human milk might be an effective treatment for preterm infants?
Research has shown that breast milk greatly benefits premature babies. Providing a mother's own milk to very small babies in the NICU offers both short- and long-term health advantages. In this trial, participants will receive varying volumes of human milk to assess its impact. Breast milk helps these babies grow better and remain healthier compared to formula. Even if direct breastfeeding is uncommon, the proven benefits of breast milk remain significant. Overall, breast milk supports optimal development for premature babies.24678
Who Is on the Research Team?
Ariel A. Salas, MD, MSPH
Principal Investigator
UAB Hospital
Are You a Good Fit for This Trial?
The MAGIC trial is for moderately preterm infants born between 27 and almost 32 weeks of gestation, weighing up to 1500 grams. They must have been fed human milk within the first two weeks after birth and reached full enteral feeding of at least 120 mL/kg/day in that time.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either 180-200 mL/kg/day or 140-160 mL/kg/day of human milk until 34 weeks corrected age
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a blood sample at 36 weeks corrected age
Post-discharge Follow-up
Optional follow-up survey completed by parents at 2-3 years of age to assess cognitive scores and growth outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Human milk
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor